Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Therapeutics|September 23, 2022
Fibromatosis mimicking relapse of a neuroendocrine tumor at 68Ga-DOTATOC positron-emission tomography/computed tomographyElena Trevisi, Ivan Facilissimo, Stefano Taraglio, et al.
International Journal of Clinical Pharmacy|November 6, 2014
Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexedIrene Alabiso, Chiara Baratelli, Maria Pia Brizzi, et al.
Expert Review of Anticancer Therapy|August 23, 2016
Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?Maria Pia Brizzi, Daniele Pignataro, Marco Tampellini, et al.
Medical Oncology (Northwood, London, England)|August 16, 2022
Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moonAnna La Salvia, Irene Persano, Elena Parlagreco, et al.
BMC Cancer|November 20, 2015
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literatureMaria Pia Brizzi, Cristina Sonetto, Marco Tampellini, et al.
Tumori|May 18, 2004
Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization studyMarco Tampellini, Raffaella Bitossi, Maria Pia Brizzi, et al.
The Oncologist|November 11, 2008
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questionsAlfredo Berruti, Maria Pia Brizzi, Daniele Generali, et al.
Endokrynologia Polska|October 26, 2018
Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two casesAnna La Salvia, Maria Pia Brizzi, Leonardo Muratori, et al.
Seminars in Oncology|May 14, 2020
Ocular metastases from neuroendocrine tumors: A literature reviewAnna La Salvia, Irene Persano, Elena Trevisi, et al.
Tumori|October 26, 2013
A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors?Azzurra Ottone, Elisa Bellini, Anna Ferrero, et al.
Pageof 6